tiprankstipranks
Trending News
More News >
Spencer Pharmaceutical (SPPH)
OTHER OTC:SPPH
US Market

Spencer Pharmaceutical (SPPH) Income Statement

Compare
9 Followers

Spencer Pharmaceutical Income Statement

Last quarter (Q0 0), Spencer Pharmaceutical's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Spencer Pharmaceutical's net income was $-509.69K. See Spencer Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 03Dec 02Dec 01
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ 10.07K$ 4.55K
EBITDA
$ -862.54K$ -2.23M$ -1.01M
Operating Income
$ -862.54K$ -2.28M$ -2.24M
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -862.54K$ -2.24M$ -2.23M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Spencer Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis